anaerobic infection

Also found in: Dictionary, Thesaurus, Encyclopedia.

anaerobic infection

an infection caused by an anaerobic organism such as Clostridium, usually occurring in deep puncture wounds that exclude air or in tissue that has diminished oxygen-reduction potential as a result of trauma, necrosis, or overgrowth of bacteria. Examples of anaerobic infection are gangrene and tetanus.

anaerobic

the absence of air.

anaerobic bacteria

see anaerobe.

anaerobic effluent treatment

is usually conducted in deep ponds where air does not penetrate. A fully contained system is also available.

anaerobic exercise

exercise at high work intensity during which the needs of muscle metabolism for oxygen exceeds the capacity of the circulation to supply it and an oxygen debt is incurred.

anaerobic infection

one caused by aerobic organisms.

References in periodicals archive ?

Anaerobic infections are usually polymicrobial, and Bacteroides fragilis is commonly isolated in such infections.

Bacteroides fragilis: a case study of bacteremia and septic arthritis

This builds finally the basis for correct microbiological diagnostics, appropriate clinical management and further basic and applied research in the field of anaerobic infections.

Bruker and University Medical Center Groningen (UMCG) Announce a Collaboration within new European Network for Rapid Identification of Anaerobes (ENRIA)

Anaerobic infections of war wounds in the Middle East.

Clostridium sphenoides bloodstream infection in man

Although the data is early, we believe it shows the promise of the lincosamide program to address anaerobic infections and again demonstrate Vicuron's internal research engine's strength in producing promising product candidates," Richard J.

Vicuron Pharmaceuticals Announces Data at ICAAC Supporting Next-Generation Lincosamide Program

Metronidazole is the drug of choice for empirical coverage of anaerobic infections.

Emergence of Metronidazole-Resistant Bacteroides fragilis, India

Tally's research interests include developing a genetic system for studying pathogenesis and antibiotic resistance in Bacteroides fragilis and the clinical study of anaerobic infections.

CUBIST PHARMACEUTICALS APPOINTS FRANCIS P. TALLY, M.D. TO VICE PRESIDENT, RESEARCH & DEVELOPMENT

In 1971, Searle began to market Flagyl for the treatment of intestinal and hepatic amebiasis, and in 1981 the company introduced Flagyl for the treatment of serious anaerobic infections.

NEW DOSAGE OF FLAGYL IS APPROVED FOR MARKETING IN THE U.S.; SHIPMENTS TO BEGIN IN JUNE